XML 40 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-based Compensation
9 Months Ended
Sep. 30, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Share-based Compensation
8. Share-based Compensation

The Company has one active stock incentive plan for employees and directors, the 2007 Stock Incentive Plan, which provides for awards of stock options to purchase shares of common stock, stock appreciation rights, restricted and unrestricted shares of common stock, restricted stock units (RSUs) and performance share awards (PSAs). In addition, the Company has one inactive stock option plan, the 1995 Stock Option Plan for Nonemployee Directors, under which previously granted options remain outstanding.

The Company recognizes compensation cost as service is rendered based on the fair value of the awards. The following summarizes share-based compensation expense recorded (in thousands):

 

     Three months ended September 30,      Nine months ended September 30,  
     2013      2012      2013      2012  

Cost of sales

   $ 199       $ 145       $ 466       $ 287   

Selling, general and administrative expenses

     678         780         1,701         1,912   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 877       $ 925       $ 2,167       $ 2,199   
  

 

 

    

 

 

    

 

 

    

 

 

 

As of September 30, 2013, unrecognized compensation expense related to the unvested portion of the Company’s RSUs and PSAs was $4.9 million which is expected to be recognized over a weighted average period of 1.9 years.

Stock Option Awards

A summary of the status of the Company’s stock options as of September 30, 2013 and changes during the nine months then ended is presented below:

 

     Options
Outstanding
    Weighted
Average
Exercise Price
per Share
     Weighted
Average
Remaining
Contractual
Life
     Aggregate
Intrinsic Value
 
                         (In thousands)  

Balance, January 1, 2013

     47,000      $ 23.19         

Options granted

     —          —           

Options exercised or exchanged

     (7,000     10.31         

Options canceled

     —          —           
  

 

 

         

Balance, September 30, 2013

     40,000        25.44         4.90       $ 309   
  

 

 

         

 

 

 

Exercisable, September 30, 2013

     40,000        25.44         4.90       $ 309   
  

 

 

         

 

 

 

The total intrinsic value, defined as the difference between the current market value and the grant price, of options exercised or exchanged during the nine months ended September 30, 2013 was $0.1 million.

 

Restricted Stock Units and Performance Awards

A summary of the status of the Company’s RSUs and PSAs as of September 30, 2013 and changes during the nine months then ended is presented below:

 

     Number of RSUs
and PSAs
    Weighted Average
Grant Date Fair Value
 

Unvested RSUs and PSAs at January 1, 2013

     243,141      $ 26.11   

RSUs and PSAs granted

     122,878        33.97   

RSUs and PSAs vested

     (92,930     23.59   

RSUs and PSAs canceled

     (13,521     26.86   
  

 

 

   

Unvested RSUs and PSAs at September 30, 2013

     259,568        30.69   
  

 

 

   

RSUs and PSAs are measured at the estimated fair value on the date of grant. RSUs are service-based awards and vest according to vesting schedules, which range from immediate to ratably over a three-year period. PSAs are service-based awards with a market-based vesting condition. Vesting of the market-based PSAs is dependent upon the performance of the market price of the Company’s stock relative to a peer group of companies and ranges from two to three years. The unvested balance of RSUs and PSAs at September 30, 2013 includes approximately 198,000 PSAs at a target level of performance; the actual number of common shares that will ultimately be issued will be determined by multiplying this number of PSAs by a payout percentage ranging from 0% to 200%.

Stock Awards

For the nine months ended September 30, 2013 and 2012, stock awards of 4,912 and 4,807 shares, respectively, were granted to non-employee directors, which vested immediately upon issuance. The Company recorded compensation expense based on the fair market value per share of the awards on the grant date of $27.49 and $23.40 in 2013 and 2012, respectively.